Robert Mulroy Net Worth & Insider Trades
Robert Mulroy - President and CEO, Merrimack Pharmaceuticals Inc
What is Robert Mulroy's Net Worth?
The current estimated net worth of Merrimack Pharmaceuticals Inc's President and CEO, Robert Mulroy, is estimated to be about $25.86M . Robert Mulroy owns about 1,683,328 units of Merrimack Pharmaceuticals Inc common stock. In the last 4 years at Merrimack Pharmaceuticals Inc, Robert Mulroy has sold an estimated value of $5.23M worth.
What is Robert Mulroy's Past Insider Trading?
Robert Mulroy's largest purchase order was 458,380 units , worth over $886.26K on March 25, 2015. Robert Mulroy's largest sale order was 200,000 units , worth over $1.97M on December 9, 2014. In total, Robert Mulroy has made about 16 transactions over 4 years of their time at Merrimack Pharmaceuticals Inc. Robert Mulroy usually trades in February, with the busiest year in 2014.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Robert Mulroy
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Robert Mulroy's' Mailing Address?
- Mailing address is Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 MA
Merrimack Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Gary L. Crocker | 2019 | $76,000 | $ | $19,258 | $ | $ | $95,258 |
| Richard Peters | 2019 | $383,676 | $294,891 | $ | $ | $935,369 | $1,613,936 |
| Jean M. Franchi | 2019 | $214,087 | $77,544 | $ | $ | $524,461 | $816,092 |
| Jeffrey A. Munsie | 2019 | $209,658 | $72,015 | $ | $ | $478,659 | $760,332 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm
What are Merrimack Pharmaceuticals Inc's Past Insider Trades?
Merrimack Pharmaceuticals Inc's most recent insider trade came on November 20, 2023 by Eric Andersen, Western Standard Llc, Western Standard Partners Lp and Western Standard Partners QP Lp who bought 300 units worth $3.75K . In the last 11 years, insiders at Merrimack Pharmaceuticals Inc have sold an estimated value of $15.57M and bought an estimated value of $31.96M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Gary L Crocker, See Remarks, Michael Porter, Director, and Edward Stewart, Head Commercial .
MERRIMACK PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||